Protagonist therapeutics set to join s&p smallcap 600

New york , june 27, 2024 /prnewswire/ -- protagonist therapeutics inc. (nasd: ptgx) will replace encore wire corp. (nasd: wire) in the s&p smallcap 600 effective prior to the opening of trading on wednesday, july 3. s&p europe 350 constituent prysmian spa (mtaa: pry) is acquiring encore wire in a deal expected to be completed soon pending final conditions.

WIRE Ratings Summary

WIRE Quant Ranking